Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1983-12-14
1987-12-22
Bond, Robert T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548452, C07D20902, A61K 3140
Patent
active
047147083
ABSTRACT:
The invention relates to derivatives of cis,endo-2-azabicyclo[5.3.0]decane-3-carboxylic acid of the formula I ##STR1## in which R denotes hydrogen, alkyl, alkenyl or aralkyl, R.sup.1 denotes hydrogen, allyl, vinyl or a side chain of an optionally protected naturally occurring .alpha.-aminoacid, R.sup.2 denotes hydrogen, alkyl, alkenyl or aralkyl, Y denotes hydrogen or hydroxyl, Z denotes hydrogen, or Y and Z together denote oxygen, X denotes alkyl, alkenyl, cycloalkyl, aryl which can be substituted once, twice or three times by alkyl, alkoxy, hydroxyl, halogen, nitro, amino, alkylamino, dialkylamino or methylenedioxy, or denotes indol-3-yl, and their physiologically acceptable salts, a process for their preparation, agents containing them and their use.
REFERENCES:
patent: 3113950 (1963-12-01), Sunagawa et al.
Becker Reinhard
Henning Rainer
Teetz Volker
Urbach Hansjorg
Bond Robert T.
Hoechst Aktiengesellschaft
Springer D. B.
LandOfFree
Derivatives of cis, endo-2-azabicyclo[5.3.0]decane-3-carboxylic does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Derivatives of cis, endo-2-azabicyclo[5.3.0]decane-3-carboxylic , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Derivatives of cis, endo-2-azabicyclo[5.3.0]decane-3-carboxylic will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-819012